Adicet Bio Director Andrew Sinclair Receives 4,200 Stock Options

This Form 4 filing reports that Andrew Sinclair, a director of Adicet Bio, Inc. (ACET), was granted 4,200 stock options on June 21, 2026. The options have an exercise price of $8.10 per share and expire on June 20, 2036. According to footnote F1, these options will vest in full on the earlier of either the first anniversary of the grant date or the date of the next annual meeting of stockholders following the grant date, subject to Sinclair's continued service on the company's board of directors. The transaction was reported by Nick Harvey as attorney-in-fact on June 23, 2026. This filing represents a standard equity compensation award to a non-employee director, which is a common practice for aligning director interests with shareholder value creation.